Pathways’ Picks February 17: Eye on Europe, Panel News, COVID Lessons, and More

article image

In this week’s roundup: A 19th notified body is designated and more news from Europe; an FDA advisory panel pans the first drug-coated balloon seeking to treat critical limb ischemia; COVID lessons considered by FDA and IMDRF; Brazil electronic instructions-for-use enforcement; CMS administrator nomination imminent and more personnel news.

Notified body, expert panel, and Eudamed news in Europe. An FDA panel votes against BD’s Lutonix paclitaxel-coated balloon as a first-in-class therapy for below-the-knee critical limb ischemia. FDA and the International Medical Device Regulators Forum reflect on COVID-19 lessons. That news and more in this week’s Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: